Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Latest News
    • India to set up Saarc...

    India to set up Saarc centre to combat drug abuse menace: Revenue Secretary Hasmukh Adhia

    Written by savita thakur thakur Published On 2016-03-17T11:59:19+05:30  |  Updated On 16 Aug 2021 2:30 PM IST
    Vienna: India is set to take a definitive "lead role" in combating money laundering and illegal funds generation from drug trafficking by establishing a regional cooperation platform for Saarc (South Asian Association for Regional Cooperation) nations soon, a top official said here.

    The proposed regional forum called the South Asian Regional Intelligence and Coordination Centre on Transnational Organised Crime (SARICC-TOC) was mooted during a meeting between the grouping's countries in New Delhi last year and should be up and working in the next six months time to share vital intelligence and information on the illicit drugs trade and trafficking in the shared region of the neighbours.

    "The SARICC-TOC should get established in the next six months. It will be a major development and will play an important role in preventing flow of money in these transnational crimes and preventing such illicit financial flows," Revenue Secretary Hasmukh Adhia told PTI on Monday.

    Adhia was here to deliver a speech at the UN Special segment of the 59th session of Commission on Narcotic Drugs.

    The Indian government, he said, is poised to take a "greater leadership role" in drug control and fighting transnational organised crime that has a negative impact on development and security.

    "This is in line with India's growing stature and geopolitical position being at the cross-roads of major drug production centres and trafficking hubs," Adhia said.

    In India, the Department of Revenue under the Finance Ministry, is the nodal empowered department mandated to frame policies to combat the narcotics menace while the enforcement
    of laws in this domain is entrusted with central agencies like the Narcotics Control Bureau and various state police departments.

    The official said India "will not only host the Council and Secretariat of this new platform in Delhi but will also be the permanent co-chair of the Council."

    In his speech, Adhia highlighted some concerns that policy making bodies and law enforcement agencies are facing to curb the illegal use of narcotics and its trafficking.

    "Money laundering and illicit financial flows and proceeds of crime generated from drug trafficking and other trans-national organised crime remain a major challenge.

    "In order to effectively counter this challenge, India has recently amended its laws related to money laundering and Foreign Exchange Management Act," he said.

    The recent changes provide for seizure and confiscation of property of equivalent value within the country, if it is established that property held abroad is in violation of FEMA and anti-money laundering legislation," Adhia said.

    Drug AbuseFEMAForeign Exchange Management ActHasmukh AdhiaSaarcSARICC-TOCSouth Asian Regional Intelligence and Coordination Centre on Transnational Organised Crime
    Source : PTI

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    savita thakur thakur
    savita thakur thakur
      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok